In addition, topical administration of GLP-1 was able to significantly reduce the downregulation of anti-apoptotic transmembrane molecule B-cell lymphoma-extra-large protein (Bcl-xL) induced by diabetes (Figure 8C,D). Here, BCL2L1 is linked to diabetes mellitus.